Canagliflozin regulates metabolic reprogramming in diabetic kidney disease by inducing fasting-like and aestivation-like metabolic patterns
Kawashima K, Fujii T, Moriwaki Y, Misawa H
If this drug class is new to you, our primer on what GLP-1 medications are and how they work covers the fundamentals before the comparison details below
A step-by-step workflow for low-level analysis of single-cell RNA-seq data with Bioconductor
doi: 10.1016/j.tcb.2022.02.003 73 BertelsL-KFernndez MurilloLHeinischJJ
J Diab Metab Disorders 19(2):18791894 Obici S, Feng Z, Arduini A, Conti R, Rossetti L (2003) Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production